| Identification | Back Directory | [Name]
LACTO-N-NEOTETRAOSE | [CAS]
13007-32-4 | [Synonyms]
LNNT
NLCOSE
NLCOSE4
Neolactotetraose
LACTO-N-NEOTETRAOSE
Lacto-N-neotetraose ,>=95%
lacto-N-neo-tetraose from human milk
Lacto-N-neotetraose (LNnT / neo-LNT)
GAL-BETA1,4GLCNA-CBETA1, 3GAL-BETA1, 4GLC
β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-D-Glc
LNnT, β-D-Gal-(1-4)-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
BETA-D-GAL-[1->4]-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
LNT/LNnT-mix[lacto-N-tetraose (type I chain)/lacto-N-neotetraose (type II chain)
D-Glucose, O-β-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,4,5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide | [Molecular Formula]
C26H45NO21 | [MDL Number]
MFCD00467190 | [MOL File]
13007-32-4.mol | [Molecular Weight]
707.63 |
| Chemical Properties | Back Directory | [Melting point ]
214-218 (trihydrate) | [Boiling point ]
1173.6±65.0 °C(Predicted) | [density ]
1.72±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C
| [solubility ]
Water (Slightly), Methanol (Slightly, Heated) | [form ]
Solid | [pka]
12.39±0.20(Predicted) | [color ]
White to Off-White | [biological source]
synthetic | [Optical Rotation]
+33 → +27 | [Stability:]
Hygroscopic | [InChIKey]
RBMYDHMFFAVMMM-IIKBCSIINA-N |
| Hazard Information | Back Directory | [Chemical Properties]
White freeze-dried powder | [Uses]
Lacto-N-neotetraose (CAS# 13007-32-4) is a polysaccaride found in human milk. Oral supplementation of lacto-N-neotetraose in healthy adults resulted in shifts the intestinal microbiota - a substantial increase in relative abundance of actinobacteria and bifidobacterium and a reduction in the abundance of firmicutes and proteobacteria. | [Definition]
ChEBI: A tetrasaccharide comprising residues of galactose, N-acetylglucosamine, galactose and glucose in a linear sequence, all joined by beta-linkages. |
|
|